BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25924762)

  • 1. Loss of Immunization-Induced Epitope-Specific CD4 T-Cell Response following Anaplasma marginale Infection Requires Presence of the T-Cell Epitope on the Pathogen and Is Not Associated with an Increase in Lymphocytes Expressing Known Regulatory Cell Phenotypes.
    Brown WC; Turse JE; Lawrence PK; Johnson WC; Scoles GA; Deringer JR; Sutten EL; Han S; Norimine J
    Clin Vaccine Immunol; 2015 Jul; 22(7):742-53. PubMed ID: 25924762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens.
    Garcia-Garcia JC; de la Fuente J; Kocan KM; Blouin EF; Halbur T; Onet VC; Saliki JT
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):137-51. PubMed ID: 15010223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and long-term disappearance of CD4+ T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live A. marginale.
    Abbott JR; Palmer GH; Kegerreis KA; Hetrick PF; Howard CJ; Hope JC; Brown WC
    J Immunol; 2005 Jun; 174(11):6702-15. PubMed ID: 15905510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation of PD-1 and LAG-3 Contributes to T-Cell Exhaustion in Anaplasma marginale-Infected Cattle.
    Okagawa T; Konnai S; Deringer JR; Ueti MW; Scoles GA; Murata S; Ohashi K; Brown WC
    Infect Immun; 2016 Oct; 84(10):2779-90. PubMed ID: 27430272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers.
    Norimine J; Han S; Brown WC
    Immunogenetics; 2006 Sep; 58(9):726-39. PubMed ID: 16924490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid deletion of antigen-specific CD4+ T cells following infection represents a strategy of immune evasion and persistence for Anaplasma marginale.
    Han S; Norimine J; Palmer GH; Mwangi W; Lahmers KK; Brown WC
    J Immunol; 2008 Dec; 181(11):7759-69. PubMed ID: 19017965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.
    Lopez JE; Palmer GH; Brayton KA; Dark MJ; Leach SE; Brown WC
    Infect Immun; 2007 May; 75(5):2333-42. PubMed ID: 17339347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge.
    Brown WC; Shkap V; Zhu D; McGuire TC; Tuo W; McElwain TF; Palmer GH
    Infect Immun; 1998 Nov; 66(11):5406-13. PubMed ID: 9784551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a.
    Brown WC; McGuire TC; Mwangi W; Kegerreis KA; Macmillan H; Lewin HA; Palmer GH
    Infect Immun; 2002 Oct; 70(10):5521-32. PubMed ID: 12228278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD4+ T cell immunodominant Anaplasma marginale major surface protein 2 stimulates gammadelta T cell clones that express unique T cell receptors.
    Lahmers KK; Norimine J; Abrahamsen MS; Palmer GH; Brown WC
    J Leukoc Biol; 2005 Feb; 77(2):199-208. PubMed ID: 15522917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplasma marginale infection with persistent high-load bacteremia induces a dysfunctional memory CD4+ T lymphocyte response but sustained high IgG titers.
    Han S; Norimine J; Brayton KA; Palmer GH; Scoles GA; Brown WC
    Clin Vaccine Immunol; 2010 Dec; 17(12):1881-90. PubMed ID: 20943884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope-based vaccines with the Anaplasma marginale MSP1a functional motif induce a balanced humoral and cellular immune response in mice.
    Santos PS; Sena AA; Nascimento R; Araújo TG; Mendes MM; Martins JR; Mineo TW; Mineo JR; Goulart LR
    PLoS One; 2013; 8(4):e60311. PubMed ID: 23579784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a T-Cell Epitope That Is Globally Conserved among Outer Membrane Proteins (OMPs) OMP7, OMP8, and OMP9 of Anaplasma marginale Strains and with OMP7 from the A. marginale subsp. centrale Vaccine Strain.
    Deringer JR; Forero-Becerra EG; Ueti MW; Turse JE; Futse JE; Noh SM; Palmer GH; Brown WC
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization-induced Anaplasma marginale-specific T-lymphocyte responses impaired by A. marginale infection are restored after eliminating infection with tetracycline.
    Turse JE; Scoles GA; Deringer JR; Fry LM; Brown WC
    Clin Vaccine Immunol; 2014 Sep; 21(9):1369-75. PubMed ID: 25008904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the msp1alpha gene of Anaplasma marginale occurs in bovine erythrocytes and tick cells.
    Garcia-Garcia JC; de la Fuente J; Blouin EF; Johnson TJ; Halbur T; Onet VC; Saliki JT; Kocan KM
    Vet Microbiol; 2004 Mar; 98(3-4):261-72. PubMed ID: 15036535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of humoral and cellular immune response of BALB/c mice immunized with a recombinant fragment of MSP1a from Anaplasma marginale using carbon nanotubes as a carrier molecule.
    Silvestre BT; Rabelo ÉM; Versiani AF; da Fonseca FG; Silveira JA; Bueno LL; Fujiwara RT; Ribeiro MF
    Vaccine; 2014 Apr; 32(19):2160-6. PubMed ID: 24606864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The repertoire of Anaplasma marginale antigens recognized by CD4(+) T-lymphocyte clones from protectively immunized cattle is diverse and includes major surface protein 2 (MSP-2) and MSP-3.
    Brown WC; Zhu D; Shkap V; McGuire TC; Blouin EF; Kocan KM; Palmer GH
    Infect Immun; 1998 Nov; 66(11):5414-22. PubMed ID: 9784552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypervariable region of Anaplasma marginale major surface protein 2 (MSP2) contains multiple immunodominant CD4+ T lymphocyte epitopes that elicit variant-specific proliferative and IFN-gamma responses in MSP2 vaccinates.
    Brown WC; Brayton KA; Styer CM; Palmer GH
    J Immunol; 2003 Apr; 170(7):3790-8. PubMed ID: 12646645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of bovines using a DNA vaccine (pcDNA3.1/MSP1b) prepared from the Jaboticabal strain of Anaplasma marginale.
    de Andrade GM; Machado RZ; Vidotto MC; Vidotto O
    Ann N Y Acad Sci; 2004 Oct; 1026():257-66. PubMed ID: 15604503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T lymphocytes from Anaplasma marginale major surface protein 2 (MSP2) vaccinees recognize naturally processed epitopes conserved in MSP3.
    Brown WC; Palmer GH; Brayton KA; Meeus PF; Barbet AF; Kegerreis KA; McGuire TC
    Infect Immun; 2004 Jun; 72(6):3688-92. PubMed ID: 15155686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.